Skip to main content

Table 32 Antimalarial activity of benzimidazole derivatives 30a and 31 g

From: Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review

Comp. Minimum inhibitory concentration (IC50 µg/mL)
31a 0.023
31b 0.003
31c 0.012
31d 0.025
31e 0.005
31f 0.26
31 g 0.15
Quinine 0.268
Chloroquine 0.020